Global emergence of Acinetobacter baumannii International Clone 12 predominantly found in the Middle East
Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) are of great concern, as mortality is high, and treatment options are very limited. Despite having among the highest rates reported worldwide, scarce genomic data are available on CRAB strains from the Middle East. Here, we report the global emergence of a novel International Clone (IC), designated IC12, based on the epidemiological, phenotypic and genome sequencing data (short reads and long reads) of a set of 60 <i>A</i>. <i>baumannii</i> isolates belonging to multilocus sequence type 158 (Pasteur scheme). IC12, prevailing in the Middle East since 2007, has also been found in Europe, Asia and South America. Alleles OXA-65 and ADC-117, coded by the <i>bla</i> <sub>OXA-51-like</sub> and <i>bla</i> <sub>ADC</sub> <i>A. baumannii</i>-intrinsic genes, respectively, were hallmarks shared by all the isolates. Plasmid pIC12-2 (80,000 bp), which carries a <i>repAci6</i> replication initiator (RP-T1) and a type IV conjugative transfer system, played a major role in the antimicrobial resistance profile of 54/60 of the IC12 isolates. This resistance was mediated by three mobile genetic elements, namely Tn<i>2008</i>, MITE<i>Ab-IC12</i> and Tn<i>aphA6</i>. All four Peruvian IC12 isolates lacked pIC12-2 and carried a different set of plasmids. Two of the Peruvian isolates carried a chromosomal resistance island of 79,396 bp long (designated IC12-RI) marked by the occurrence of <i>tet</i>(X3). The global spread of IC12 is worrying and calls for further studies on the virulence features and clinical impact of this clone.
Authors
- Louis‐Patrick Haraoui (ORCID: https://orcid.org/0000-0002-3713-7866)
- Frank Hansen
- Leena Al-Hassan (ORCID: https://orcid.org/0000-0002-0506-050X)
- Monzer Hamzé (ORCID: https://orcid.org/0000-0001-7466-5118)
- Antoine Abou Fayad (ORCID: https://orcid.org/0000-0002-7516-7919)
- Rémy A. Bonnin (ORCID: https://orcid.org/0000-0002-2307-3232)
- Santiago Castillo‐Ramírez (ORCID: https://orcid.org/0000-0003-3922-7088)
- Xavier Didelot (ORCID: https://orcid.org/0000-0003-1885-500X)
- Nabil Karah (ORCID: https://orcid.org/0000-0001-8867-658X)
- Anette M. Hammerum (ORCID: https://orcid.org/0000-0001-9471-1601)
- Benjamin A. Evans (ORCID: https://orcid.org/0000-0001-6849-9758)
- Simon Lévesque (ORCID: https://orcid.org/0000-0002-4356-9702)
- Bernt Eric Uhlin (ORCID: https://orcid.org/0000-0002-2991-8072)
- Sébastien Rodrigue (ORCID: https://orcid.org/0000-0002-5366-7234)
- Rayane Rafei (ORCID: https://orcid.org/0000-0001-9633-1290)
- Nancy Allard (ORCID: https://orcid.org/0009-0004-9996-7058)
- Paul G. Higgins (ORCID: https://orcid.org/0000-0001-8677-9454)
- Laurent Poirel (ORCID: https://orcid.org/0000-0001-5160-5286)
- Nathan Faille
- Frédéric Grenier (ORCID: https://orcid.org/0000-0003-3910-3165)
Institutions
- Brighton and Sussex Medical School (GB)
- Statens Serum Institut (DK)
- Université Paris-Sud (FR)
- Canadian Institute for Advanced Research (CA)
- University of East Anglia (GB)
- Université de Sherbrooke (CA)
- University of Fribourg (CH)
- Lebanese University (LB)
- University of Cologne (DE)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- University of Warwick (GB)
- Hôpital Charles-Le Moyne (CA)
- German Center for Infection Research (DE)
- Centre Intégré de Santé et de Services Sociaux des Laurentides (CA)
- Centre intégré de santé et de services sociaux de Chaudière-Appalaches (CA)
- University Hospital Cologne (DE)
- Bicêtre Hospital (FR)
- Universidad Nacional Autónoma de México (MX)
- Umeå University (SE)
- American University of Beirut (LB)
Publication Details
- Journal
- Microbial Genomics
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1099/mgen.0.001572
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canadian Institute for Advanced Research
- Vetenskapsrådet
- Umeå Universitet
- Medicinska fakulteten, Umeå Universitet